Market: NMS |
Currency:
Address:
π EART Historical Chart
π Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
-
-
EPS Growth Range (1Y):
-
-
Net Income Growth Range (1Y):
-
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
π° Dividend History
No dividend history available.
π
Earnings & EPS History for EART
No earnings history available for this symbol.
π° Related News & Research
-
HeartSciences Announces Passing of COO Mark Hilz; No Changes to Product Plans or Leadership Structure
April 4, 2026
HeartSciences Inc. 8-K Filing Analysis β April 2026 Heart...
-
Hall Chadwick Acquisition Corp. Announces $600M De-SPAC Deal with REEcycle Holdings to Advance U.S. Rare Earth Recycling Industry 1
April 1, 2026
Hall Chadwick Acquisition Corp. Announces LOI with REEcycle ...
-
Ramaco Resources Announces Strategic Corporate Reorganization to Unlock Shareholder Value and Accelerate Rare Earth & Critical Minerals Growth 1234
March 31, 2026
Ramaco Resources Announces Strategic Internal Corporate Reor...
-
USA Rare Earth Reports 2025 Financial Results, Secures $1.6B Funding to Accelerate Rare Earth Supply Chain Expansion and Magnet Manufacturing
March 30, 2026
USA Rare Earth (USAR) Q4 2025 and FY 2025 Earnings: Comprehe...
-
USA Rare Earth, Inc. 2025 Annual Report: Building a Resilient Mine-to-Magnet Supply Chain for Critical Minerals and Rare Earth Elements
March 30, 2026
USA Rare Earth, Inc. 2025 Annual Report: Key Insights for In...
-
Picard Medical, Inc. 2025 Annual Report: SynCardia Total Artificial Heart, Business Strategy, Risks, and Regulatory Outlook
March 30, 2026
Picard Medical, Inc. 2025 Annual Report β Key Investor Highl...
-
Picard Medicalβs SynCardia Total Artificial Heart: 2025 Business Update, Next-Gen Technology Pipeline, and Growth Strategy
March 28, 2026
Picard Medical (NYSE: PMI) 2025 Annual Business Update: Key ...
-
BioLargo, Inc. Signs Registration Rights and Purchase Agreement with ClearThink Capital Partners, LLC
March 26, 2026
BioLargo, Inc. Enters \$10 Million Equity Purchase Agreement...
-
Lionheart Holdings 2025 Annual Report: Business Strategy, Management, and SPAC Investment Criteria Explained
March 26, 2026
Lionheart Holdings 2025 Annual Report: Key Highlights for In...
-
Chuan Holdings Limited Announces 132.9% Surge in Net Profit for FY2025 Driven by Property Investment and Earthworks Segment 12
March 26, 2026
Chuan Holdings Limited Issues Positive Profit Alert for FY20...
π View more Reports